Image Place holder

Jyotishankar Raychaudhuri, MD

Specialty: Hematology/Oncology
Program: Malignant Hematology and Cellular Therapy at Memorial Healthcare System

Call 1-888-MOFFITT

Call 1-888-MOFFITT

Locations: Moffitt Malignant Hematology & Cellular Therapy at Memorial Healthcare System

Cancer Types Treated: Multiple Myeloma-Plasma Cell Tumor , Myelodysplastic Syndromes (MDS) , Non-Hodgkin Lymphoma , Hodgkin Lymphoma , Leukemia

Dr. Jyotishankar Raychaudhuri is a blood and marrow transplant specialist at Moffitt Malignant Hematology and Cellular Therapy at Memorial Healthcare System in Pembroke Pines. Dr. Raychaudhuri earned his medical degree at All India Institute of Medical Sciences in New Delhi, India. He completed residencies in radiology and radiotherapy, internal medicine, and pathology in India, as well as a residency and fellowship in internal medicine at Lincoln Hospital, affiliated with New York Medical School. He completed another fellowship in hematology/oncology at Winthrop University Hospital in New York, and served as a post-doctoral fellow in a molecular biology and biochemistry lab at Cold Spring Harbor Laboratory in New York. In addition to providing patient care, Dr. Raychaudhuri also teaches and trains medical students and young physicians. He has taught at various institutions including New York Medical College at Metropolitan Hospital, Cornell University Medical Center, Moffitt Cancer Center and the USF Morsani College of Medicine. He is also a manuscript reviewer for the journal of Clinical Myeloma and Lymphoma and a member of the Acute Leukemia Writing Committee, as part of the Center for International Blood & Marrow Transplant Research (CIBMTR). Most recently, Dr. Raychaudhuri served as a senior consultant for Blood and Marrow Transplantation at Apollo Indraprastha Hospital in New Delhi, India. He has also served as assistant professor of Blood and Marrow Transplantation at the H. Lee Moffitt Cancer Center & Research Institute in Tampa.

Education & Training

Board Certification:

  • Medical Oncology
  • Hematology


  • Lincoln Hospital, New York Medical College - Internal Medicine
  • Winthrop University Hospital Mineola, SUNY at Stony Brook - Hematology/Oncology
  • Cold Spring Harbor Laboratory - Molecular Biology and Biochemistry


  • All India Institute of Medical Sciences (New Delhi, India) - Radiology and Radiotherapy
  • Sir Ganga Ram and Associated Hospitals (New Delhi, India) - Internal Medicine
  • King Edward Memorial Hospital, Bombay University (Bombay, India) - Pathology
  • Lincoln Hospital, New York Medical College - Internal Medicine
Participating Trials

If you believe you are eligible for one of these trials or studies, please call
813-745-6100 or toll-free 1-800-679-0775.


  • Nishihori T, Alekshun TJ, Shain K, Sullivan DM, Baz R, Perez L, Pidala J, Kharfan-Dabaja MA, Ochoa-Bayona JL, Fernandez HF, Yarde DN, Oliveira V, Fulp W, Han G, Kim J, Chen DT, Raychaudhuri J, Dalton W, Anasetti C, Alsina M. Bortezomib salvage followed by a Phase I/II study of bortezomib plus high-dose melphalan and tandem autologous transplantation for patients with primary resistant myeloma. Brit J Haematol. 2012 Jun;157(5):553-563. Pubmedid: 22449149. Pmcid: PMC4030553.
  • Santarone S, Pidala J, Di Nicola M, Field T, Alsina M, Ayala E, Janssen W, Kharfan-Dabaja MA, Ochoa L, Perez L, Perkins J, Raychaudhuri J, Fernandez H, Anasetti C. Fludarabine and pharmacokinetic-targeted busulfan before allografting for adults with acute lymphoid leukemia. Biol Blood Marrow Tr. 2011 Oct;17(10):1505-1511. Pubmedid: 21385623.
  • Liu JJ, Zhang L, Ayala E, Field T, Ochoa-Bayona JL, Perez L, Bello CM, Chervenick PA, Bruno S, Cultrera JL, Baz RC, Kharfan-Dabaja MA, Raychaudhuri J, Sotomayor EM, Sokol L. Human immunodeficiency virus (HIV)-negative plasmablastic lymphoma: a single institutional experience and literature review. Leuk Res. 2011 Dec;35(12):1571-1577. Pubmedid: 21752466.
  • Hoda D, Pidala J, Salgado-Vila N, Kim J, Perkins J, Bookout R, Field T, Perez L, Ayala E, Ochoa-Bayona JL, Raychaudhuri J, Alsina M, Greene J, Janssen W, Fernandez HF, Anasetti C, Kharfan-Dabaja MA. Sirolimus for treatment of steroid-refractory acute graft-versus-host disease. Bone Marrow Transplant. 2010 Aug;45(8):1347-1351. Pubmedid: 19966849.
  • Raychaudhuri J, Cualing H, Haider K, Kharfan-Dabaja M. Granulocytic sarcoma and chronic lymphocytic leukemia of the gastrointestinaltract after allogeneic hematopoietic cell transplantation mimickinggraft-versus-host disease. Leuk Lymphoma. 2008 Feb;49(2):350-352. Pubmedid: 18231925.